secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001437402-25-000008
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx appoints Sue Hohenleitner as CFO
----------------------------------------

- Appointed Sue Hohenleitner as CFO effective Nov 4, 2025; she joins Oct 13, 2025.
- Hohenleitner previously VP & CFO of J&J Innovative Medicine NA ($36B business).
- Annual base salary $550,000, target bonus 45% of base, sign-on bonus $180,000.
- Received option to purchase 578,104 shares at $5.01/share and 146,896 RSUs, four-year vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000143740225000008/0001437402-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000143740225000008/ardx-20251013.htm
  HTML page:      https://secwatch.observer/filing/0001437402-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer